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Background: The human receptor tyrosine kinase MET and its ligand hepatocyte growth factor/scatter factor are
essential during embryonic development and play an important role during cancer metastasis and tissue
regeneration. In addition, it was found that MET is also relevant for infectious diseases and is the target of different
bacteria, amongst them Listeria monocytogenes that induces bacterial uptake through the surface protein internalin
B. Binding of ligand to the MET receptor is proposed to lead to receptor dimerization. However, it is also discussed
whether preformed MET dimers exist on the cell membrane.
Results: To address these issues we used single-molecule fluorescence microscopy techniques. Our photobleaching
experiments show that MET exists in dimers on the membrane of cells in the absence of ligand and that the
proportion of MET dimers increases significantly upon ligand binding.
Conclusions: Our results indicate that partially preformed MET dimers may play a role in ligand binding or MET
signaling. The addition of the bacterial ligand internalin B leads to an increase of MET dimers which is in agreement
with the model of ligand-induced dimerization of receptor tyrosine kinases.
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The MET receptor tyrosine kinase (RTK) and its physio-
logical ligand hepatocyte growth factor/scatter factor
(HGF/SF) play an essential role in vertebrate development
as well as in tissue regeneration including proliferation,
migration, cell survival and differentiation [1]. Deregulated
MET activation is found in different forms of cancer. In
addition, pathogenic bacteria exploit MET and its signal-
ing pathways for infection. Listeria monocytogenes, the
causative agent of human listeriosis, initiates its entry into
normally non-phagocytic host cells with the surface
protein internalin B (InlB) [2,3]. InlB is non-covalently
attached to the bacterial cell wall but also released into* Correspondence: Hartmut.Niemann@uni-bielefeld.de;
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reproduction in any medium, provided the orthe medium [4]. Soluble InlB binds and activates MET
leading to similar cell responses as those elicited by HGF/
SF [3,5].
Ligand-induced dimerization of the receptor ectodo-
main constitutes the widely accepted paradigm for the
activation of RTKs [6]. However, there are exceptions like
the insulin receptor, which is constitutively dimeric. The
structural basis and the molecular mechanism of receptor
activation vary widely between different RTKs and need to
be worked out experimentally for each pair of receptor
and ligand [6,7]. In the case of the MET receptor and its
physiological ligand HGF/SF, the mechanism of receptor
activation is still not completely understood. Structural
studies have not yet provided a clear-cut picture of the
signaling-active complex [8] and small angle X-ray scatter-
ing showed that active HGF/SF only forms a 1:1 complex
with the complete MET ectodomain in solution [9]. There
is ample evidence showing that forced MET dimerization,
e.g. by antibodies or other dimeric ligands, can activate
the receptor (reviewed in [7]). However, even in thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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MET receptors from various tumor cell lines can be
cross-linked into dimers [10] and larger multimers were
found on different cell lines [11]. Hence, it remains an
open question whether MET activation by HGF/SF and
InlB really proceeds through dimerization of initially
monomeric receptors.
Like HGF/SF, InlB is a multi-domain protein. The
high-affinity binding site for MET is located within the
N-terminal internalin domain of InlB (amino acids 36–
321; InlB321) [3,5]. The soluble, monomeric internalin
domain of InlB is sufficient to induce MET phosphoryl-
ation in various cell lines [5,12,13]. In analogy to other
RTKs, this receptor activation is expected to proceed
through ligand-induced dimerization of the MET extra-
cellular domain. Crystallography revealed a biologically
plausible 2:2 complex of InlB321 bound to a large part of
the MET ectodomain (Figure 1) and mutagenesis and
cellular assays established that a contact stabilizing this
2:2 complex is important for InlB-mediated MET activa-
tion [5,13], lending further support to the proposedFigure 1 Crystal structure of the MET-InlB complex (PDB ID
2UZY). MET is shown in yellow and orange, InlB321 in cyan and blue.
L280, which was mutated to cysteine for attachment of ATTO647N,
is shown in red. (A) Top view along the 2-fold axis onto the plane of
the membrane. (B) Side view with the membrane-proximal end of
MET pointing down.MET dimerization upon binding of InlB [7]. In solution,
however, the complex between InlB321 and the complete
MET ectodomain is strictly monomeric and 2:2 com-
plexes were not observed by a variety of biochemical
and biophysical methods [5,14]. The question, whether
binding of InlB321 to MET on cells does actually induce
receptor dimerization has not yet been addressed
experimentally.
Studying receptor oligomerization in a native cellular
environment is challenging. Among the different ap-
proaches, single-molecule fluorescence microscopy is an
ideal tool as it can resolve heterogeneities and subpopu-
lations [15]. For example, receptor oligomerization was
studied using single-molecule intensity analysis in living
cells [16]. Single-molecule photobleaching has developed
to a reliable technique to investigate the number of sub-
units in protein complexes and determine the stoichiom-
etry of membrane receptors [17-20].
So far, fluorescence microscopy has been largely
neglected in the study of MET and HGF/SF. Two fusions
of a fluorescent protein to the C-terminus of MET were
reported [21,22], but the recombinant proteins were
overexpressed from strong promoters which limits their
utility for studying ligand-induced MET dimerization, as
strong overexpression is known to result in ligand-
independent MET dimerization [10,23,24]. Accordingly,
these fluorescent MET fusions have not been used for
mechanistic analysis at the molecular level. Likewise,
site-specific fluorescent labeling of HGF/SF has, to the
best of our knowledge, not been reported so far.
Here, we use single-molecule photobleaching to study
the oligomerization of endogenous MET on intact HeLa
cells by targeting with a fluorophore-labeled ligand,
InlB321. We find that MET exists partially as monomer
prior to stimulation, and observe an increased amount
of dimers upon stimulation by InlB321. Our results con-
tribute to the current understanding of the mechanism
of signal transduction by the MET receptor.
Results and discussion
Receptor density determined by single-molecule super-
resolution imaging
Single-molecule photobleaching experiments require a
molecular density sufficiently low to ensure the detec-
tion of single, spatially separated receptor clusters.
Often, the spatial density of an endogeneous membrane
receptor is too high. For example, the number of MET
receptors per cell reported varies widely from hundreds
to a hundred thousand per cell [25-29]. We determined
the total number of endogenous MET receptors on
HeLa cells using direct stochastic optical reconstruction
microscopy (dSTORM) [30]. This technique provides a
sufficient spatial resolution in order to resolve individual
receptor sites and thus to estimate the total number of
Figure 2 FCS binding curve of MET928 titrated against InlB-
ATTO647N. The diffusion time τD of the complex is plotted
against the receptor concentration. The binding curves are fitted
by a Langmuir 1:1 binding model. The diffusion time of InlB-
ATTO647N in the absence of MET is marked as green line. The
inflection point represents the dissociation constant
Kd = 5.0 ± 0.8 nM.
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directed against the human MET ectodomain and a
secondary antibody labeled with the photoswitchable
fluorophore Alexa Fluor 647, and quantified the number
of MET receptors per cell (Additional file 1: Figure S1).
We found an average receptor density of 6.5 ± 0.6 (s.d.)
molecules / μm2, roughly corresponding to 4600 to 8700
MET molecules per HeLa cell with an estimated surface
ranging from 700 to 1300 μm2. This value is within pre-
viously published numbers of receptors [25-29]. How-
ever, the receptor density is too high for stoichiometric
labeling of MET for single-molecule photobleaching, as
the fluorescence signal of single receptors would over-
lap. We thus used a fluorophore-labeled ligand, InlB321,
at concentrations which only yield a fractional labeling
of MET.
Site-specifically, fluorescently labeled InlB321 binds MET
with nanomolar affinity in vitro
For single-site labeling of InlB321 we mutated L280 to
cysteine, because its side chain is surface exposed and it
is not involved in any binding interface of the 2:2 InlB:
MET complex (Figure 1). ATTO647N, which we used
due to its excellent photophysical properties, was
attached to C280 using maleimide coupling resulting in
singly labeled InlB321. The degree of labeling (DOL) was
determined from absorption measurements to be 0.5.
We will henceforth refer to this protein as InlB-
ATTO647N. We used fluorescence correlation spectros-
copy (FCS) to assess whether InlB-ATTO647N is still
able to interact with the MET receptor. The MET
ectodomain (MET928) was titrated in a concentration
range from 0.01 nM to 1–2 μM against 1 nM InlB-
ATTO647N. After a minimum of 3 h incubation, FCS
curves were recorded and approximated with a two-
dimensional diffusion model [31]. The resulting diffusion
time plotted against the concentration of MET928 was
fitted to a 1:1 binding model resulting in a dissociation
constant Kd = 5.0 ± 0.8 nM (Figure 2). Thus, our FCS
studies revealed that InlB-ATTO647N is functional
in vitro. We had previously attempted to determine the
Kd for InlB321 and MET using surface plasmon reson-
ance (SPR) with either InlB coupled to the sensor chip
and MET as analyte [32] or MET coupled to the chip
and InlB as analyte [33] yielding values of 20–30 nM
and ~150 nM, respectively. Enzyme linked immune sor-
bent assays with immobilized MET928 and dimeric GST-
InlB321 fusion proteins [33,34] or monomeric InlB321
[32] yielded half-maximal binding roughly between 1 nM
and 5 nM. In these experiments artifacts might arise from
immobilization (e.g. causing steric hindrance preventing
conformational changes), from the use of the dimeric
GST-InlB (reflecting avidity rather than true affinity) or
from effects like mass transport in SPR. We assume thatthe Kd reported here represents the most reliable value,
as the FCS measurements were carried out in solution
and the fluorescent label is not expected to interfere
with MET binding (Figure 1).Visualization of single MET receptors
We used InlB-ATTO647N in order to study the
multimerization state of the MET receptor in HeLa cells
before and after stimulation. The resting state was imaged
by chemically fixing serum-starved HeLa cells before incu-
bation with InlB-ATTO647N. This approach is based on
the assumption that InlB-ATTO647N cannot induce
receptor dimerization if added to the cells only after fix-
ation. InlB-stimulated cells were prepared by incubating
HeLa cells with InlB-ATTO647N at 4°C for 1 h prior to
chemical fixation. The fluorescence signal was recorded at
the basal membrane of the cell in total internal reflection
(TIR) mode. Under our experimental conditions of 10 nM
concentration of InlB-ATTO647N, we found a receptor
density of 0.6 ± 0.2 (s.d.) molecules / μm2. Hence, only
about 10% of all endogenous receptors were labeled with
InlB-ATTO647N, due to a partial occupation of the
receptor with ligand (expected to be 67% at a ligand
concentration of 10 nM assuming a Kd of 5 nM), the
DOL of InlB-ATTO647N (0.5) and additional factors such
as ligand adsorption to the glass slide or photobleaching
of the fluorophore prior to the experiment. In addition,
we did observe few larger clusters which were excluded
from single-molecule analysis.
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dimerization
We observed the step-wise photobleaching by analyzing
fluorescence intensity over time in single fluorescent
spots (Figure 3). In the case of cells that were fixed prior
to addition of InlB321, we mainly observed one-step
photobleaching (Figure 3A). In the case of InlB321 stimu-
lation before cell fixation, two-step photobleaching indi-
cated the presence of two InlB in a diffraction-limited
spot and thus receptor dimerization (Figure 3B).
We evaluated the single-molecule data quantitatively
by analyzing the fluorescence intensity in single spots
using a similar approach as published earlier [19]. As a
control, we analyzed a single-molecule surface of InlB-
ATTO647N on an L-lysine coated glass surface. The TIRF
image showed clearly separated fluorescence spots, and
the single-molecule intensity distribution can be fitted
with a single Gaussian function (Figure 4A). In the case
of uninduced cells, this distribution can be approximated
with two Gaussian functions where the standard devia-
tion σ2 of the second Gaussian is
ffiffiffi
2
p
σ1 with σ1 being
the standard deviation of the monomeric intensity
distribution (Figure 4B). We observed 82% spots origi-
nating from monomeric receptors and 18% dimers. In
the case of InlB-induced cells, this distribution changed
in favor of the dimeric fraction which increased to 29%
(Figure 4C). These results suggest that MET is present
both as monomers and as dimers in the absence ofFigure 3 Single-molecule photobleaching of MET receptor. (A) Fluores
HeLa cells. In most cases, one-step photobleaching was observed. The hist
(B) InlB induced cells show an increase in two-step photobleaching of fluoInlB-ATTO647N, and that binding of InlB-ATTO647N
increases the fraction of dimers significantly.
The actual fraction of dimers is clearly underestimated
in the single-molecule intensity analysis due to non-
stoichiometric labeling of MET, although this cannot be
easily calculated from the current data. Notwithstanding
this uncertainty, single-molecule microscopy clearly
showed that InlB stimulation results in increased MET
dimerization on intact cells. This resolves the apparent
contradiction that a MET ligand induces receptor
phosphorylation in cellular assays although it does not
promote dimerization of the MET ectodomain in solu-
tion. Membrane anchorage of MET in cellular assays
reduces the dimensionality of diffusion from 3 dimen-
sions in solution to 2 dimensions in the plane of the
membrane. Reducing the dimensionality of diffusion is
an important concept in many biological processes that
can reduce diffusion times [35] or increase apparent
affinities [36]. We can thus envisage the following order
of events: monomeric InlB binds with high affinity to
MET receptors, which are present as both monomers
and dimers on the cell. The 1:1 complexes diffuse two-
dimensionally within the membrane plane and even-
tually form low-affinity 2:2 complexes [37].
Our observation by fluorescence microscopy of MET
dimers on cells that were not treated with HGF/SF or
InlB is consistent with previously reported data from
chemical cross-linking. In several tumor cell lines,cence intensity trajectories found for InlB-ATTO647N in uninduced
ograms on the right show the distribution of fluorescence intensities.
rescence spots, reporting on MET dimers.
Figure 4 Binding of InlB to MET induces receptor dimerization. Single-molecule data were background-corrected and single-fluorophore
intensity distributions extracted. (A) Individual fluorescence spots of single InlB-ATTO647N adsorbed to an L-lysine coated glass surface (top).
Fluorescence spots selected for intensity analysis are marked with green squares (7x7 pixels) (scale bar 2 μm). The intensity distribution of
individual InlB-ATTO647N molecules (n = 404) was well fitted with a single Gaussian function. (B) TIRF image of an uninduced cell. The
distribution of fluorescence intensities was fitted by two Gaussian functions (n = 527 spots from 17 cells were analyzed). (C) TIRF image of an
induced cell. The intensity distribution shows an increase of the fraction of receptor dimers (n = 421 spots from 10 cells). Numbers on histograms
indicate maxima and fractions.
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absence of ligand [10,38]. An important role of the Sema
domain for ligand-independent MET dimerization was
shown [10], and Sema domains from semaphorins
generally form homodimers [39]. However, there is no
crystallographic evidence for homodimerization of the
MET Sema domain so far. Instead, one could also envi-
sage a mechanism of ligand-independent MET dimeri-
zation that does not involve the MET ectodomain. A
MET construct lacking the complete ectodomain is
constitutively active, suggesting that the transmembrane
domain and/or the juxtamembrane and kinase domain
of MET may promote dimerization [40]. Both the trans-
membrane and the intracellular domain also contribute
to dimerization of other RTKs like EGFR [41,42].
This leaves us with several questions: What is the
importance of preformed MET dimers? Do ligands pre-
ferentially bind to preformed receptor dimers? Are the
preformed dimers signaling active or do they require
ligand binding for signaling? Right now we can only
speculate about these issues for MET. For other receptor
systems, however, answers are already available. For some
cytokine receptors like the erythropoietin receptor or the
growth hormone receptor dimerization is required but
not sufficient for signaling. In addition, a particularorientation of the two receptors in the dimer seems to be
important. These receptors appear to exist as preformed
dimers and ligand binding may result in a rotational or
translational movement of the protomers relative to each
other [43,44]. Very recently, a computational study repor-
ted such relative movements of the receptor molecules as
a model for cytokine receptor activation [45]. Single mo-
lecule fluorescence microscopy has also provided evidence
for preformed dimers of unliganded EGFR on cells, but
ligand binding was still required for signaling [46,47].
Conclusion
Our data clearly show that the receptor tyrosine kinase
MET exists as both monomers and preformed dimers in
the absence of ligand. To our knowledge we have experi-
mentally shown for the first time that the addition of the
bacterial ligand InlB leads to increased MET dimerization.
This result is consistent with the well-established model
of ligand-induced dimerization of receptor tyrosine kina-
ses. The importance of the preformed dimers remains
elusive. Clarifying the complete mechanism of MET re-
ceptor activation will require a multidisciplinary approach
employing complimentary experimental techniques. For
sure, single-molecule fluorescence microscopy has the
potential to contribute exciting insights to this endeavor.
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Expression and purification of internalin B
InlB321 was expressed as tobacco etch virus (TEV) prote-
ase cleavable glutathione-S-transferase (GST) fusion pro-
tein. In addition to the K280C mutation, the naturally
occurring C242 was mutated into alanine in order to
prevent the formation of undesired intramolecular disu-
lfide bonds during folding. Banerjee et al. [12] had already
shown that this mutation does not impair MET binding.
The C242A and K280C mutations were introduced
into the previously described pETM30 vector [5] using
QuikChange® mutagenesis kit (Stratagene). Transformed
Escherichia coli BL21-CodonPlus(DE3)-RIL were grown
in lysogeny broth (LB) medium containing kanamycin and
chloramphenicol at 37°C to an optical density at 600 nm
(OD600) of 0.6. After induction with 0.1 mM isopropyl β-
D-1-thiogalactopyranoside bacteria were incubated with
shaking at 20°C overnight. Cells were harvested by centri-
fugation. The bacterial pellet was washed with phosphate
buffered saline (PBS), resuspended in PBS containing a
complete protease inhibitor cocktail tablet (Roche) and
DNaseI (2.4 μg/mL), and lysed by three passes through a
French pressure cell press. After centrifugation, the
cleared lysate was applied for 1 h at 4°C to 10 mL of
glutathione sepharose affinity matrix (GE Healthcare)
equilibrated in PBS. After extensive washing with first PBS
and then TEV protease cleavage buffer (50 mM Tris, pH
8.0, 0.5 mM EDTA, 20 mM NaCl, 1 mM DTT), the resin
was resuspended in 40 mL of TEV cleavage buffer and
40 μL of 1 M DTT were added. The target protein was
cleaved off from the GST-tag by incubation with 0.5 mg of
TEV protease at room temperature overnight. The libe-
rated target protein was eluted and further purified by
anion exchange chromatography. InlB321 was applied to
Source Q 15 (GE Healthcare) equilibrated in 20 mM Tris,
pH 7.5 and eluted with a linear salt gradient up to 300
mM NaCl over 10 column volumes.
Labeling of internalin B with ATTO647N
For fluorescence labeling, fresh InlB321 was used directly
after elution from the anion exchange column. The main
fraction from Source Q 15 was covered with nitrogen
and tris(2-carboxyethyl)phosphine (TCEP) was added to
a final concentration of 0.5 mM. For each labeling reac-
tion, 100 μg of ATTO647N maleimide (ATTO-TEC)
dissolved in 5 μL of dry dimethylformamide (DMF) were
used. Immediately before the labeling, a 3-fold molar
excess of TCEP was added to the protein and a 3-fold
molar excess of ATTO647N maleimide over protein was
incubated with InlB321 in the dark at room temperature
for 1 h. Excess fluorophore was removed using a PD10
desalting column (GE Healthcare) equilibrated in PBS.
The elution of the PD10 column was fractionated.
Coomassie stained sodium dodecyl sulfate polyacrylamidegel (SDS-PAGE) was used to assess protein purity and to
roughly estimate the degree of labeling (DOL). The
protein concentration and the DOL were determined
spectrophotometrically using absorption at 280 and 644
nm. The DOL was calculated using the formula DOL =
[A644*ε280(protein)] / ([A280 – A644*CF]*ε644(fluorophore)).
The correction factor CF corrects for the absorption of
ATTO647N at 280 nm and its value of 0.05 was experi-
mentally determined by calculating A280/A644 measured
for pure ATTO647N maleimide. Labeled InlB321 was
stored at −20°C in the dark.
Expression and purification of MET928
The soluble MET ectodomain (MET928) was expressed
in glycosylation deficient Chinese hamster ovary (CHO)
lec8 cells and purified essentially as described previously
[5,9,48]. Size exclusion chromatography on a Superdex
200 column (GE Healthcare) equilibrated in PBS was
used as final purification step in order to obtain only
monomeric MET928 that was used for fluorescence
correlation spectroscopy.
Cell culture
HeLa cells were cultured on chamber slides and grown
for 24 h in RPMI 1640 medium containing 100 IU/mL
penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine
and 5% fetal calf serum at 37°C in 5% CO2. Before the
experiment, the cells were serum starved for 24 h.
Binding of InlB to MET on HeLa cells
For resting cells, HeLa cells were fixed with 4% formal-
dehyde in phosphate buffered saline (PBS) (pH 7.4) for
10 min. After washing with PBS, the cells were incu-
bated with 10 nM of the InlB-ATTO647N construct in
PBS for 1 h at 4°C. For InlB induced cells, living HeLa
cells were cooled for 10 min at 4°C to prevent internal-
ization of MET upon InlB binding. 10 nM InlB-
ATTO647N in RPMI medium were added and binding
occurred within 1 h at 4°C. Afterwards, the cells were
washed with ice cold PBS and fixed with 4% formalde-
hyde for 10 min.
Immunofluorescence
HeLa cells were grown and serum starved as described
above. To prevent de novo protein synthesis, cells were
incubated with 50 μM cycloheximide (Sigma-Aldrich) in
starvation medium for 2 h. The cells were fixed with 4%
formaldehyde for 10 min. After washing with PBS, cells
were blocked with blocking buffer (5% BSA in PBS) for
1 h at room temperature. The polyclonal primary
antibody directed against the complete ectodomain of
human MET (AF276, R&D Systems) was added to the
cells at a concentration of 2 μg/mL in blocking buffer.
Cells were incubated for 2 h at room temperature and
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body labeled with Alexa Fluor 647 (rabbit anti-goat IgG,
Invitrogen) was added at a concentration of 2 μg/mL in
blocking buffer. After 1 h incubation, cells were washed
three times with PBS.
Fluorescence correlation spectroscopy
The FCS measurements were performed using a home-
built confocal microscope (for detailed information see
[31,49]). ATTO647N was excited at 638 nm using a
diode laser (Cube 635, Coherent). Photobleaching was
avoided by using very low excitation intensities (200
μW, measured at the back aperture of the objective).
The laser beam was coupled into an oil-immersion
objective (63×, NA 1.4; Zeiss) by a dichroic beam splitter
(645DLRP, Omega Optics). The emission light was
collected by the same objective, passed a band-pass filter
(700DF75, Omega Optics), separated into two beams
using a cubic non-polarizing beamsplitter (Linos) and
coupled into two multi-mode optical fibers with a
diameter of about 100 μm. The signal was detected by
the active area of two single-photon avalanche photodi-
odes (AQR-14, Perkin Elmer) and the signals of these
photodiodes were cross-correlated (5 min for each mea-
surement) using a digital real-time multi-tau correlator
device (ALV-6010, ALV GmbH) with a time resolution
of 6.25 ns.
For sample preparation, the dye-labeled InlB321 was
diluted to a final concentration of 1 nM in 0.05%
Tween-20 in PBS. The MET928 ectodomain was added
in different end concentrations in the range from
0.01 nM to 1–2 μM. The total volume in each reaction
tube was 100 μL. After thoroughly mixing, the complex
formation was allowed to occur for at least 3 h at room
temperature. The reaction mixtures were transferred
onto a microscope slide and covered with a coverslip.
Each measurement was done at a constant depth of 40
μm from the glass surface. The temperature of the
objective was kept constant at 20°C by a custom-made
heating block.
FCS data analysis is described in detail elsewhere [31].
In brief, fluctuations in the fluorescence signal I(t) due
to diffusion of the dye labeled MET928-InlB321 complex
in and out of the detection volume were analyzed via the
second-order autocorrelation function:
G τð Þ ¼ I tð ÞI t þ τð Þ
I tð Þ2
Here, 〈 〉 denotes the time average over the total
observation time. Approximation of this equation can be
done by using a two-dimensional diffusion model for a
single species in combination with a stretched exponen-
tial decay accounting for photophysical processes.G τð Þ ¼ 1
N
1þ τ
τD
 −1
1þ K ∙ exp − τ
τrel
 β !
with N the number of detected molecules, τD the diffu-
sion time, K the amplitude, τrel the rate constant, and β
the stretch parameter of a decay accounting for
photophysical processes. The diffusion time τD depends
on the dimensions of the detection focus ωxy in x,y-
dimension and the diffusion constant D as
τD ¼ ω2xy=4D
By measuring the diffusion times at different concen-
trations of MET928, a complete binding curve could be
determined. Plotting the diffusion time τD against the
MET928 concentration and fitting with a simple 1:1
binding model allows estimation of the dissociation
constant Kd of the MET928-InlB321 complex.
τD ¼ τInlB þ τInlB−MET−τInlBð Þ MET½ Kd þ MET½ 
where τInlB and τInlB −MET are the diffusion times of free
InlB and of the MET928-InlB321 complex.
Single-molecule microscopy
The experimental setup consisted of an inverted micro-
scope (Olympus IX-71) equipped with an oil-immersion
objective (60x, NA 1.45, Olympus). The 647 nm laser
line from an argon krypton laser (Coherent) was selected
by an acousto-optic tunable filter (AAOptics), passed a
dichroic beamsplitter (FF560/659, Sembrock) and focused
onto the back focal plane of the microscope lens. Total
internal reflection fluorescence (TIRF) configuration
allowed for near-surface illumination of ATTO647N or
Alexa Fluor 647, respectively. The emission light is filtered
in the detection path by a bandpass (ET700/75, AHF
Analysentechnik) and a longpass filter (LP647RU, AHF
Analysentechnik) and detected on an electron-multiplying
charge-coupled device (EMCCD) camera (Ixon DU897,
Andor).
Single-molecule surface of InlB-ATTO647N
Glass coverslips were cleaned by incubating with 1 M
HCl overnight. After washing thoroughly with bidistilled
water and 100 mM NaHCO3 (pH 8.5), the surface was
covered with 0.1% poly-L-lysine (Sigma-Aldrich) in
water. The coverslips were incubated for 10 min at room
temperature. The solution was removed and the poly-L
-lysine coated glass surface was dried. The surface was
washed with 100 mM phosphate buffer (pH 7.3) before
incubation with InlB-ATTO647N (0.1 nM) in phosphate
buffer for 5 min. Finally, the glass surface was washed
with PBS.
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Single-molecule photobleaching was performed in TIR
mode. For enhancing the photostability of ATTO647N
100 mM β-mercaptoethylamine (MEA) in PBS was added.
Movies of 1000 to 3000 frames were recorded with 33 Hz
using an irradiation intensity of about 0.3 kW/cm2.
To analyze photobleaching steps, movies were back-
ground-corrected with the rolling ball method using
ImageJ (NIH). Photobleaching intensity time traces were
extracted from regions of 7×7 pixel size. For the analysis
of the fluorescence intensity distribution the open-
source image analysis software ICY (Institut Pasteur)
was used [50]. The background corrected first frame of
each movie was analyzed using a custom script (Fabrice
de Chaumont) which includes the Spot Detector
plugin in ICY. A threshold was set, a 7×7 pixels region
of interest was built around the center of mass of each
detection and the overall intensity was calculated.
Frequency distributions of the fluorescence intensities
were generated with OriginPro 8.6G (OriginLab).Receptor counting: imaging and data analysis
For receptor counting, immunostained MET was imaged
with the dSTORM technique. For imaging a “switching
buffer” containing oxygen scavenger (0.5 mg/mL glucose
oxidase (Sigma), 40 μg/mL catalase (Sigma), 10% w/v
glucose) and MEA (100 mM) in PBS was used. Super-
resolution fluorescence microscopy was performed as
described earlier [30] with the above mentioned experi-
mental setup in TIR mode. Observation parameters were
10 000 frames recorded with 20 Hz using irradiation
intensities of about 1 kW/cm2.
The number of InlB bound to receptor was analyzed
using the background corrected photobleaching movies.
Super-resolved images of the dSTORM and photoblea-
ching data were reconstructed using the rapidSTORM
software. The resulting images were further analyzed in
terms of particle numbers with the ImageJ plugin “3D
object counter”.Additional file
Additional file 1: Figure S1. dSTORM imaging of MET receptor in fixed
HeLa cells. MET was immunostained with Alexa Fluor 647. (A)
Comparison of wide field and super-resolution dSTORM images (scale bar
2 μm). (B) Enlarged section (2 × 2 μm²) of the inset in (A), (C) dSTORM
image of the section in (B).
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